PYPD

PolyPid Ltd. Ordinary Shares

$5.07 +7.42%

Recent alerts on PYPD

All signals →

SEC filing PYPD Completes FDA NDA Submission for D-PLEX 100, Targets Q1 2027 Approval, Phase 3 Shows 60% SSI Reduction

News PolyPid GAAP EPS of -$0.35 beats by $0.08

SEC filing PYPD Reports Q4 Net Loss $8.5M, ($0.41) EPS; Advances D-PLEX₁₀₀ Commercialization, Sees FDA Rolling NDA Submission Q1 2026

Get push alerts for PYPD

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS